John H. Massie

50 Flemington Road
Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Resolution of Refractory Chylous Effusions With Targeted MEK Inhibition in NRAS Q61R-Driven Kaposiform Lymphangiomatosis: A Case Report.

Resolution of Refractory Chylous Effusions With Targeted MEK Inhibition in NRAS Q61R-Driven Kaposiform Lymphangiomatosis: A Case Report.

Journal: Case reports in pediatrics

Published: March 23, 2026

Ethical Considerations With CFTR Modulator Use in Pregnancy.

Ethical Considerations With CFTR Modulator Use in Pregnancy.

Journal: Pediatric pulmonology

Published: February 25, 2026

Viral Induced Hypersecretion of Mucous (VIper): Proposal for a Distinct Phenotype of Viral Induced Lower Respiratory Tract Infection in Children.

Viral Induced Hypersecretion of Mucous (VIper): Proposal for a Distinct Phenotype of Viral Induced Lower Respiratory Tract Infection in Children.

Journal: Pediatric pulmonology

Published: February 16, 2026

What Is a Paediatrician? Reflection on the Specialty of Paediatrics.

What Is a Paediatrician? Reflection on the Specialty of Paediatrics.

Journal: Journal of paediatrics and child health

Published: January 15, 2026

Progression of structural lung disease and lung function in adolescents with cystic fibrosis.

Progression of structural lung disease and lung function in adolescents with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 22, 2025

Australasian guideline for the performance of sweat chloride testing 3rd edition: to support cystic fibrosis screening, diagnosis and monitoring.

Australasian guideline for the performance of sweat chloride testing 3rd edition: to support cystic fibrosis screening, diagnosis and monitoring.

Journal: Clinical chemistry and laboratory medicine

Published: April 07, 2025

Revising the reproductive story: psychosocial and reproductive impacts 12 months after reproductive genetic carrier screening.

Revising the reproductive story: psychosocial and reproductive impacts 12 months after reproductive genetic carrier screening.

Journal: European journal of human genetics : EJHG

Published: March 03, 2025

Offering reproductive genetic carrier screening for cystic fibrosis, spinal muscular atrophy and fragile X syndrome: Views of Victorian general practitioners.

Offering reproductive genetic carrier screening for cystic fibrosis, spinal muscular atrophy and fragile X syndrome: Views of Victorian general practitioners.

Journal: Australian journal of general practice

Published: December 18, 2024

Prospective parents' views on reproductive genetic carrier screening: "You know better, you do better".

Prospective parents' views on reproductive genetic carrier screening: "You know better, you do better".

Journal: Journal of genetic counseling

Published: December 04, 2024

Guidelines for reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy.

Guidelines for reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy.

Journal: Pathology

Published: November 27, 2024

Nationwide, Couple-Based Genetic Carrier Screening.

Nationwide, Couple-Based Genetic Carrier Screening.

Journal: The New England journal of medicine

Published: November 20, 2024

Ethical challenges of multiple organ transplant in cystic fibrosis.

Ethical challenges of multiple organ transplant in cystic fibrosis.

Journal: The Medical journal of Australia

Published: May 08, 2024

Showing 1-12 of 104

Last Updated: 09/26/2026